Kamil Drucis
University Clinical Centre · 42 works · 3,516 citations · h-index 10
Top works
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- 3301 Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma
- Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
- Three-year estimate of overall survival in COMBI-v, a randomized phase 3 study evaluating first-line dabrafenib (D) + trametinib (T) in patients (pts) with unresectable or metastatic BRAF V600E/K–mutant cutaneous melanoma
- MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
- Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
- Jan Mikulicz‐Radecki (1850–1905): Pioneer of Endoscopy and Surgery of the Sinuses, Throat, and Digestive Tract
- Nonlinear modeling with mammographic evidence of carcinoma
- Simultaneous Determination of Na+, K+, Ca2+, Mg2+ and Cl− in Unstimulated and Stimulated Human Saliva Using All Solid State Multisensor Platform
- [Pseudomyxoma peritonei spread into the right inguinal hernia sac--a case report].
- Combi-V: a Randomised, Open-Label, Phase III Study Comparing the Combination of Dabrafenib (D) and Trametinib (T) with Vemurafenib (V) As First-Line Therapy in Patients (Pts) with Unresectable or Metastatic Braf V600E/K Mutation-Positive Cutaneous Melanoma
- The influence of radioisotope vehicle on breast sentinel node detection
- Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
- Correlation between the drainage time in dynamic indocyanine green lymphography (ICG) and axillary lymph nodes metastatic involvement in breast cancer patients—a prospective study
- The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
- Epithelioid malignant peripheral nerve sheath tumour – a case report of rapid progression
- Nail apparatus melanoma: epidemiological, clinical and histopathological analysis
- Porocarcinoma of the nail: A dermoscopic observation
- Fluorescence Imaging Using Methylene Blue Sentinel Lymph Node Biopsy in Melanoma
- Metachronous adenocarcinoma in a gastric tube after radical surgery for oesophageal cancer